GeoVax Labs Files 8-K on Shareholder Vote Matters
Ticker: GOVX · Form: 8-K · Filed: Jan 22, 2025 · CIK: 832489
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: GOVX
TL;DR
GeoVax (GOVX) filed an 8-K today about a shareholder vote. Details TBD.
AI Summary
On January 22, 2025, GeoVax Labs, Inc. filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing does not specify the nature of the vote or any outcomes, but it indicates a formal process involving shareholder decisions is underway.
Why It Matters
This filing signals that GeoVax Labs is engaging its shareholders in a formal decision-making process, which could impact the company's future direction or corporate actions.
Risk Assessment
Risk Level: medium — The filing indicates a shareholder vote is occurring, which can introduce uncertainty and potential changes to the company's structure or strategy.
Key Players & Entities
- GeoVax Labs, Inc. (company) — Registrant
- January 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39563 (filing_id) — Commission File Number
- 87-0455038 (tax_id) — IRS Employer Identification Number
FAQ
What specific matters are being submitted for a vote by GeoVax Labs, Inc. security holders?
The filing states that matters are being submitted to a vote of security holders, but it does not specify the exact nature of these matters.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on January 22, 2025.
In which state is GeoVax Labs, Inc. incorporated?
GeoVax Labs, Inc. is incorporated in Delaware.
What is the Commission File Number for GeoVax Labs, Inc.?
The Commission File Number is 001-39563.
What is the IRS Employer Identification Number for GeoVax Labs, Inc.?
The IRS Employer Identification Number is 87-0455038.
Filing Stats: 579 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2025-01-22 16:01:47
Key Financial Figures
- $0.001 — ch registered Common Stock , par value $0.001 per share GOVX The Nasdaq Capital Ma
Filing Documents
- govx20250122_8k.htm (8-K) — 27KB
- 0001437749-25-001556.txt ( ) — 171KB
- govx-20250122.xsd (EX-101.SCH) — 4KB
- govx-20250122_def.xml (EX-101.DEF) — 13KB
- govx-20250122_lab.xml (EX-101.LAB) — 17KB
- govx-20250122_pre.xml (EX-101.PRE) — 13KB
- govx20250122_8k_htm.xml (XML) — 5KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. The Company re-convened a special meeting of stockholders on January 22, 2025 (originally convened on September 17, 2024). The Company received proxies totaling 1,675,334 of its 5,013,700 issued and outstanding shares of common stock as of the record date of July 22, 2024, representing 33.4% of the outstanding shares of common stock entitled to vote. The stockholders voted on the following proposals and the results of the voting are presented below. Approval of the May 2024 Warrant Exercise Proposal Our stockholders approved a proposal to approve, pursuant to Nasdaq listing rules, the issuance of up to 1,605,688 shares of our common stock upon exercise of a common stock purchase warrant issued to an institutional investor in connect with the private placement offering which occurred on May 16, 2024. There were no broker non-votes on this item. For Against Abstain 1,294,141 287,649 93,544 Approval of the July 2024 Warrant Exercise Proposal Our stockholders approved a proposal to approve, pursuant to Nasdaq listing rules, the issuance of up to 2,170,000 shares of our common stock upon exercise of a common stock purchase warrant issued to an institutional investor in connect with the private placement offering which occurred on July 11, 2024. There were no broker non-votes on this item. For Against Abstain 1,306,150 275,705 93,479 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 22, 2025 GEOVAX LABS, INC. By: /s/ Mark W. Reynolds Mark W. Reynolds Chief Financial Officer 2